Author bets Harvard Bioscience will exceed $1 after a debt refinancing and new CEO, ahead of expected strong earnings.
HBIO — LONG The author argues HBIO dropped below $1 only due to bad management, and that a new CEO plus a completed debt refinancing put the company in a position where it is in its own interest to keep the ticker listed. He expects upcoming earnings to confirm strong financials, betting the stock hits $1+. The stated risk is that investors are waiting to confirm the last quarter's financials before buying.
With earnings coming up, I’m betting this thing hits $1+
This Reddit post, published January 12, 2026, features u/Legal-Industry-731 discussing HBIO. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/Legal-Industry-731 · Tickers: HBIO